Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

17DD yellow fever vaccine | Synapse

January 30, 2013Open Access

Ver artículo completo

17DD yellow fever vaccine

RMReinaldo de Menezes MartinsFundação Oswaldo Cruz MMMaria de Lourdes S. MaiaMinistério da Saúde RFRoberto FariasInstituto de Biologia do Exército

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

In young healthy adults Bio-Manguinhos/Fiocruz yellow fever vaccine can be used in much lower doses than usual. INTERNATIONAL REGISTER: ISRCTN 38082350.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Martins et al. (Wed,) studied this question.

synapsesocial.com/papers/69de655b7ed287395e558b48 https://doi.org/https://doi.org/10.4161/hv.22982

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses2001 · 72 citations
2Circulating Virus, Interferon and Antibody after Vaccination with the 17-D Strain of Yellow-Fever Virus1965 · 121 citations
3Anamnestic immune response to dengue and decreased severity of yellow fever2009 · 42 citations
4WINPEPI (PEPI-for-Windows): computer programs for epidemiologists2004 · 457 citations
5[Relation between viremia and sero-antibodies to the anti-yellow fever vaccination of persons vaccinated with strain 17D-EP].1971 · 5 citations